- WB
Unknown
Western blot - Anti-Calcipressin 1/RCAN1 antibody [EPR8911] (AB140131)
All lanes:
Western blot - Anti-Calcipressin 1/RCAN1 antibody [EPR8911] (ab140131) at 1/10000 dilution
All lanes:
Human fetal heart lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 28 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (1)
-
Anti-Calcipressin 1/RCAN1 antibody [EPR8911] - BSA and Azide free
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Within the cell RCAN1 functions as a modulator of calcineurin-dependent transcriptional activity. It interacts with several proteins including those in the signaling complex linked to the NFAT (nuclear factor of activated T-cells). By managing the activity of calcineurin RCAN1 influences the transcription of genes involved in growth development and immune responses. Therefore its role is critical in maintaining cellular homeostasis and response to changes in calcium levels.
Pathways
RCAN1 impacts the calcineurin-NFAT signaling and MAPK (mitogen-activated protein kinase) pathways. In the calcineurin-NFAT pathway RCAN1 influences T-cell activation and the immune response by modulating NFAT's transcriptional activity. Moreover the MAPK pathway which is important for cell proliferation and differentiation sees regulation through RCAN1's action on calcineurin interfacing with kinases like JNK (c-Jun N-terminal kinase) to adjust signaling outputs.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (6)
Recent publications for all applications. Explore the 전체 목록 and refine your search
World journal of gastroenterology 31:105554 PubMed40495950
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 15:406 PubMed38858351
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 11: PubMed36429004
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of bone oncology 30:100383 PubMed34336566
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 52:865-875 PubMed32467610
2020
Applications
Unspecified application
Species
Unspecified reactive species
Physiological reports 6:e13912 PubMed30430766
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com